Pharmacy Access Laws Would Increase Drug Costs, FTC Says
This article was originally published in The Pink Sheet Daily
Executive Summary
In a letter to Rhode Island officials, FTC says bills mandating that health plans contract with "any willing provider" would restrict competitive forces and limit consumer choice. FTC also faults the bills for proposing to ban mail-order pharmacy.
You may also be interested in...
PBM Regulation In Maine Blocked By Federal Court; ERISA Preempts State
Judge Woodcock sides with Pharmaceutical Care Management Association on two of three arguments against Maine law that sought to define the relationship between PBMs and "covered entities" as fiduciary and thereby require further transparency from PBMs.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.